This HTML5 document contains 161 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1200/
n10https://w3id.org/oc/corpus/br/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q27852177
rdf:type
wikibase:Item
schema:description
naučni članak 2013年論文 scientific article 2013 թվականի հունիսին հրատարակված գիտական հոդված наукова стаття, опублікована в червні 2013 научни чланак artigo científico (publicado na 2013) vedecký článok (publikovaný 2013/06/01) 2013年論文 2013년 논문 vitenskapelig artikkel articolo scientifico (pubblicato il 2013/06/01) ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículu científicu espublizáu en 2013 artículo científico publicado en 2013 teaduslik artikkel 2013年论文 bài báo khoa học bilimsel makale article científic 2013年論文 სამეცნიერო სტატია مقالهٔ علمی vitskapeleg artikkel επιστημονικό άρθρο 2013年の論文 article scientifique (publié 2013) บทความทางวิทยาศาสตร์ 2013年论文 2013 թուականի Յունիսին հրատարակուած գիտական յօդուած мақолаи илмӣ article scientific научна статия artigo científico мақолаи илмӣ מאמר מדעי 2013年论文 مقالة علمية (نشرت في يونيو 2013) scienca artikolo artikull shkencor artykuł naukowy tudományos cikk wissenschaftlicher Artikel научни чланак 2013年论文 2013年論文 wetenschappelijk artikel (gepubliceerd op 2013/06/01) tieteellinen artikkeli mokslinis straipsnis 2013年論文 artigo científico (publicado na 2013/06/01) 2013年论文 2013 nî lūn-bûn научная статья videnskabelig artikel (udgivet 2013/06/01) سائنسی مضمون vědecký článek publikovaný v roce 2013 articol științific 2013年论文 artikulong pang-agham vetenskaplig artikel
p:P577
wds:Q27852177-7FB5214B-7439-41CE-A5F7-86B2053BF9E3
wdt:P577
2013-04-08T00:00:00Z
p:P407
wds:Q27852177-6CB4F982-CF76-4252-BD89-42EBFCB44C3A
wdt:P407
wd:Q1860
p:P2860
wds:Q27852177-0BA59B18-45A0-4F31-8058-BD88897C4260 wds:Q27852177-0BB6896A-0169-4A23-B6C3-54DC44A94F26 wds:Q27852177-0EED6324-B78A-416F-B331-990B570F9506 wds:Q27852177-2193F252-FB18-4549-9F27-5A301406E222 wds:Q27852177-247F5351-19FB-40A9-8201-CAB4D6ED7D59 wds:Q27852177-43930A6A-7A37-4D17-8B05-409D70BB17D5 wds:Q27852177-6057A150-329D-4370-B7FA-BCC22EC894BC wds:Q27852177-68D68BC7-EF0C-4FF6-92F6-66B251B5D3DC wds:Q27852177-6A4EE93B-1333-405B-A69B-463F79E5F43F wds:Q27852177-7A79F698-A1C6-457C-BFAC-B36F72831A25 wds:Q27852177-84194832-1ED8-4CA4-B8FC-F2FEF773F0DB wds:Q27852177-ADC21127-FA00-4A9C-937F-2C37C29BEA70 wds:Q27852177-AF17D8B2-8428-4A28-97A1-46C1B757C8E0 wds:Q27852177-CC526675-54E9-481A-B164-F151A180A48B wds:Q27852177-E806A03F-60B5-49D2-89A4-94558473C0FA
wdt:P2860
wd:Q44436731 wd:Q31004603 wd:Q81352887 wd:Q35931388 wd:Q40492303 wd:Q37823790 wd:Q34026081 wd:Q53286509 wd:Q40440656 wd:Q28131668 wd:Q54561402 wd:Q64112087 wd:Q53540062 wd:Q34629045 wd:Q35034758
p:P2093
wds:Q27852177-0607F933-D40F-46E5-B04B-F631321FBFC2 wds:Q27852177-96A3318D-CE3F-499D-8918-A215A0E24D0B wds:Q27852177-F31B4B89-22DB-4CC7-A48B-372EC92061AB wds:Q27852177-E2E8DE47-26A5-41F8-911D-ECC2FFA9248E wds:Q27852177-B603D062-2AF7-4E3B-BAC8-CEA36E8A5E1C wds:Q27852177-A71ED6E4-0711-4204-B4BC-967F128B2CC7 wds:Q27852177-61971FE8-8418-4038-8AE5-60127C6BB6CD wds:Q27852177-70C731C9-3A85-4AAC-8AAF-ABDE65A8FDE6 wds:Q27852177-6BC124D1-9D2D-4DC9-94F6-6D323D9869D2
p:P3181
wds:Q27852177-56936EEC-8F8C-4D40-B19B-24CCE87E2E53
wdtn:P3181
n10:1311308
wdt:P2093
Yelena Ustoyev Mark A Dickson Mercedes M Condy Cristina R Antonescu Mary Louise Keohan Dustin D Rathbone Gary K Schwartz William D Tap Li-Xuan Qin
wdt:P3181
1311308
rdfs:label
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
skos:prefLabel
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
schema:name
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
p:P50
wds:Q27852177-2E3D48C6-47D4-405B-835A-9B7E27D75C37 wds:Q27852177-2FC50384-BBB0-4ABA-AF61-853F9EF7EB68 wds:Q27852177-276EE1F2-B797-4870-8704-62FF0DDF9E88 wds:Q27852177-1A4226BB-A22B-4436-8F0D-67844053406A wds:Q27852177-023D0248-5594-499B-9E1E-AC26C45622D1
wdt:P50
wd:Q57040158 wd:Q64210897 wd:Q41050083 wd:Q92508279 wd:Q37830046
p:P1476
wds:Q27852177-05A16DCE-6D30-4D56-B2F6-8697C2266FBB
wdt:P1476
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
p:P304
wds:Q27852177-67DADAB3-D588-4F4E-8F51-01B1C5DA511B
wdt:P304
2024-2028
p:P31
wds:Q27852177-6B7EDEB6-B4DE-4976-9275-0D5F6FADA498
wdt:P31
wd:Q13442814
p:P921
wds:Q27852177-2824A882-C978-43B2-BF71-EA61FB4DCBBD wds:Q27852177-8972F2B8-D6DC-4180-AB47-9A0C6F6AB169
wdt:P921
wd:Q42824440 wd:Q181600
p:P698
wds:Q27852177-82145C8B-C239-40A5-A115-7FE5E1D3E3DA
wdtn:P698
n12:23569312
wdt:P698
23569312
p:P1433
wds:Q27852177-8C2BE56B-3DDE-4028-8854-69C443017979
wdt:P1433
wd:Q400292
p:P433
wds:Q27852177-87C05E25-BE18-4645-BAF1-B52A6CE4736D
p:P478
wds:Q27852177-5AE76A7C-7A72-425C-B7D8-094F92DB24D7
wdt:P433
16
wdt:P478
31
p:P356
wds:Q27852177-7FAA7CE1-4922-492E-847F-315C0D6D37B6
wdtn:P356
n11:JCO.2012.46.5476
wdt:P356
10.1200/JCO.2012.46.5476
skos:altLabel
Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
p:P932
wds:Q27852177-4A703762-BE95-4B11-854E-98FF9F87CC65
wdt:P932
3661937